It is noteworthy that the proposed radiomics signature does not require a priori knowledge of grading information because it behaved well for distinguishing MGMT methylation status not only in a grade II-IV cohort, but also in grade II, III and IV astrocytomas, separately. Here, MGMT is linked to astrocytoma (excluding glioblastoma).